Evaluating Maternaae Opti-fiber Supplement and Counselling for Managing Constipation in Pregnant Women

What This Trial Is About

Researchers are evaluating the effectiveness of a daily Fiber Nutritional Supplement called Maternaae Opti fiber, which contains partially hydrolyzed guar gum PHGG and vitamins C, D, zinc, and selenium, combined with nutritional counselling. This study focuses on managing constipation during pregnancy, a common gastrointestinal issue that can affect quality of life and well-being. The trial is open label and single arm, enrolling pregnant women between 13 and 27 weeks of gestation who meet specific criteria for functional constipation. Participants will receive one sachet per day of the fiber supplement providing about 5.8 grams of PHGG for 4 weeks. In addition to the supplement, all participants will get standardized constipation counselling at the start, which includes education on constipation and lifestyle advice. This study involves a single group receiving this combined intervention. Throughout the study, participants will be monitored for changes in stool frequency from baseline to 4 weeks. Researchers will also assess stool consistency, symptoms of constipation and gut discomfort, healthcare and medication use related to constipation, and product acceptance. Participants will complete questionnaires in English and are expected to comply with study requirements, including avoiding other fiber or probiotic supplements during the intervention period.

Fiber Nutritional Supplement for Management of Constipation During Pregnancy